Literature DB >> 9253572

Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients.

S J George1, P Vuddamalay, M J Boscoe.   

Abstract

The incidence of bacterial colonization of central venous catheters using a standard polyurethane catheter was compared with that using an antiseptic (silver sulphadiazine and chlorhexidine) impregnated catheter in a group of patients with thoracic organ transplantation. Colonization was reduced from 25 of 35 standard catheters to 10 of 44 study catheters (P < 0.002), a 68% reduction. Similarly, the incidence of concomitant infection, by the same organism at another site was reduced from 10 of 35 standard catheters to 4 of 44 study catheters (P < 0.03), a 63% reduction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9253572     DOI: 10.1046/j.1365-2346.1997.00168.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  10 in total

1.  The relationship between methodological trial quality and the effects of impregnated central venous catheters.

Authors:  Christine Geffers; Irina Zuschneid; Tim Eckmanns; Henning Rüden; Petra Gastmeier
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

Review 2.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Authors:  B S Niël-Weise; T Stijnen; P J van den Broek
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

4.  Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients.

Authors:  Sarah K Wassil; Catherine M Crill; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

5.  Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.

Authors:  Torben Ostendorf; Andrea Meinhold; Christoph Harter; Hans Salwender; Gerlinde Egerer; Heinrich K Geiss; Antony D Ho; Hartmut Goldschmidt
Journal:  Support Care Cancer       Date:  2005-04-16       Impact factor: 3.603

6.  Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use.

Authors:  Mohamed A Jamal; Kumait Garoge; Joel S Rosenblatt; Ray Y Hachem; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

Review 7.  New technologies to prevent intravascular catheter-related bloodstream infections.

Authors:  L A Mermel
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

8.  Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation.

Authors:  Yoon Ji Choi; Jae Kwan Lim; Jeong Jun Park; Hyub Huh; Dong-Joo Kim; Chang-Hoon Gong; Seung Zhoo Yoon
Journal:  J Int Med Res       Date:  2017-05-23       Impact factor: 1.671

Review 9.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16

10.  Can a new antiseptic agent reduce the bacterial colonization rate of central venous lines in post-cardiac surgery patients?

Authors:  Fardin Yousefshahi; Khashayar Azimpour; Mohammad Ali Boroumand; Mahdi Najafi; Khosro Barkhordari; Mitra Vaezi; Nahid Rouhipour
Journal:  J Tehran Heart Cent       Date:  2013-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.